Sunday, January 30, 2011

Urinary Incontinence (UI) - Drug Pipeline Analysis and Market Forecasts to 2016


Urinary Incontinence (UI) – Drug Pipeline Analysis and Market Forecasts to 2016

GlobalData, the industry analysis specialist’s new report, “Urinary Incontinence– Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global urinary incontinence market. The report identifies the key trends shaping and driving the global urinary incontinence market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global urinary incontinence sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
  • The report provides information on the key drivers and challenges in the global UI market. It includes:
  • Annualized global UI market revenues data from 2001 to 2009, forecast for seven years to 2016.
  • Key geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include acetylcholine antagonists/blockers, muscarinic receptor antagonists, beta-3 adrenoceptor antagonists, calcium influx inhibitors and intracellular calcium modulators, nonpeptide δ-receptor agonists, neuronal serotonin and norepinephrine reuptake inhibitors, vanilloid receptor agonists, beta-3 adrenergic receptor agonists, noradrenaline reuptake inhibitors and NK1 receptor antagonists.
  • Analysis of the current and future market competition in the global UI market. The key market players covered are Pfizer Inc., Allergan Inc., Kissei Pharmaceuticals and Astellas Pharma.
  • An insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • The key topics covered include a strategic competitor assessment, a market characterization, unmet needs and implications for the future UI market.
Reasons to buy
  • The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
  • Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global urinary incontinence market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global urinary incontinence market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Buy Now : Market Research

Related Reports

    at